The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis.
<h4>Background</h4>Bronchiolitis exerts a high burden on children, their families and the healthcare system. The Canadian Bronchiolitis Epinephrine Steroid Trial (CanBEST) assessed whether administering epinephrine alone, dexamethasone alone, or in combination (EpiDex) could reduce bronc...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0318853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849689700357373952 |
|---|---|
| author | Larry Dong Terry P Klassen David W Johnson Rhonda Correll Serge Gouin Maala Bhatt Hema Patel Gary Joubert Karen J L Black Troy W S Turner Sandra R Whitehouse Amy C Plint Anna Heath |
| author_facet | Larry Dong Terry P Klassen David W Johnson Rhonda Correll Serge Gouin Maala Bhatt Hema Patel Gary Joubert Karen J L Black Troy W S Turner Sandra R Whitehouse Amy C Plint Anna Heath |
| author_sort | Larry Dong |
| collection | DOAJ |
| description | <h4>Background</h4>Bronchiolitis exerts a high burden on children, their families and the healthcare system. The Canadian Bronchiolitis Epinephrine Steroid Trial (CanBEST) assessed whether administering epinephrine alone, dexamethasone alone, or in combination (EpiDex) could reduce bronchiolitis-related hospitalizations among children less than 12 months of age compared to placebo. CanBEST demonstrated a statistically significant reduction in 7-day hospitalization risk with EpiDex in an unadjusted analysis but not after adjustment.<h4>Objective</h4>To explore the probability that EpiDex results in a reduction in hospitalizations using Bayesian methods.<h4>Study design</h4>Using prior distributions that represent varying levels of preexisting enthusiasm or skepticism, i.e., how confident or doubtful one is that EpiDex may reduce hospitalizations, and information about the treatment effect before data were collected, the posterior distribution of the relative risk of hospitalization compared to placebo was determined. The probability that the treatment effect is less than 1, 0.9, 0.8 and 0.6, indicating increasing reductions in hospitalization risk, are computed alongside 95% credible intervals.<h4>Results</h4>Combining a minimally informative prior distribution with the data from CanBEST provides comparable results to the original analysis. Unless strongly skeptical views about the effectiveness of EpiDex were considered, the 95% credible interval for the treatment effect lies below 1, indicating a reduction in hospitalizations. There is a 90% probability that EpiDex results in a clinically meaningful reduction in hospitalization of 10% even when incorporating skeptical views, with a 67% probability when considering strongly skeptical views.<h4>Conclusion</h4>A Bayesian analysis demonstrates a high chance that EpiDex reduces hospitalization rates for bronchiolitis, although strongly skeptical individuals may require additional evidence to change practice.<h4>Trial registration</h4>Clinical Trial registry name, registration number: Current Controlled Trials number, ISRCTN56745572. |
| format | Article |
| id | doaj-art-e91004caab704628aef5f36bfbac9305 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e91004caab704628aef5f36bfbac93052025-08-20T03:21:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e031885310.1371/journal.pone.0318853The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis.Larry DongTerry P KlassenDavid W JohnsonRhonda CorrellSerge GouinMaala BhattHema PatelGary JoubertKaren J L BlackTroy W S TurnerSandra R WhitehouseAmy C PlintAnna Heath<h4>Background</h4>Bronchiolitis exerts a high burden on children, their families and the healthcare system. The Canadian Bronchiolitis Epinephrine Steroid Trial (CanBEST) assessed whether administering epinephrine alone, dexamethasone alone, or in combination (EpiDex) could reduce bronchiolitis-related hospitalizations among children less than 12 months of age compared to placebo. CanBEST demonstrated a statistically significant reduction in 7-day hospitalization risk with EpiDex in an unadjusted analysis but not after adjustment.<h4>Objective</h4>To explore the probability that EpiDex results in a reduction in hospitalizations using Bayesian methods.<h4>Study design</h4>Using prior distributions that represent varying levels of preexisting enthusiasm or skepticism, i.e., how confident or doubtful one is that EpiDex may reduce hospitalizations, and information about the treatment effect before data were collected, the posterior distribution of the relative risk of hospitalization compared to placebo was determined. The probability that the treatment effect is less than 1, 0.9, 0.8 and 0.6, indicating increasing reductions in hospitalization risk, are computed alongside 95% credible intervals.<h4>Results</h4>Combining a minimally informative prior distribution with the data from CanBEST provides comparable results to the original analysis. Unless strongly skeptical views about the effectiveness of EpiDex were considered, the 95% credible interval for the treatment effect lies below 1, indicating a reduction in hospitalizations. There is a 90% probability that EpiDex results in a clinically meaningful reduction in hospitalization of 10% even when incorporating skeptical views, with a 67% probability when considering strongly skeptical views.<h4>Conclusion</h4>A Bayesian analysis demonstrates a high chance that EpiDex reduces hospitalization rates for bronchiolitis, although strongly skeptical individuals may require additional evidence to change practice.<h4>Trial registration</h4>Clinical Trial registry name, registration number: Current Controlled Trials number, ISRCTN56745572.https://doi.org/10.1371/journal.pone.0318853 |
| spellingShingle | Larry Dong Terry P Klassen David W Johnson Rhonda Correll Serge Gouin Maala Bhatt Hema Patel Gary Joubert Karen J L Black Troy W S Turner Sandra R Whitehouse Amy C Plint Anna Heath The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. PLoS ONE |
| title | The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. |
| title_full | The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. |
| title_fullStr | The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. |
| title_full_unstemmed | The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. |
| title_short | The probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone: A Bayesian analysis. |
| title_sort | probability of reducing hospitalization rates for bronchiolitis with epinephrine and dexamethasone a bayesian analysis |
| url | https://doi.org/10.1371/journal.pone.0318853 |
| work_keys_str_mv | AT larrydong theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT terrypklassen theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT davidwjohnson theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT rhondacorrell theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT sergegouin theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT maalabhatt theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT hemapatel theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT garyjoubert theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT karenjlblack theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT troywsturner theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT sandrarwhitehouse theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT amycplint theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT annaheath theprobabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT larrydong probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT terrypklassen probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT davidwjohnson probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT rhondacorrell probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT sergegouin probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT maalabhatt probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT hemapatel probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT garyjoubert probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT karenjlblack probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT troywsturner probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT sandrarwhitehouse probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT amycplint probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis AT annaheath probabilityofreducinghospitalizationratesforbronchiolitiswithepinephrineanddexamethasoneabayesiananalysis |